Cleared Traditional

K930866 - RASCAL II

K930866 is the FDA 510(k) clearance for RASCAL II by Ohmeda Medical. It is a Class 2 Anesthesiology device (product code CCK) cleared through the Traditional 510(k) pathway after a 83-day FDA review.

K930866 · Ohmeda Medical · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
83d
Days
Class 2
Risk

K930866 is an FDA 510(k) clearance for the RASCAL II. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Ohmeda Medical (Salt Lake City, US). The FDA issued a Cleared decision on May 13, 1993 after a review of 83 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ohmeda Medical devices

Submission Details

510(k) Number K930866 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 1993
Decision Date May 13, 1993
Days to Decision 83 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 140d · This submission: 83d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 124
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K930866.
AS/3(TM) ANESTHESIA MONITOR SYST INTERFACE BOARD
K935477 · Datex Division Instrumentarium Corp. · Aug 1994
AS/3 TM NETWORK
K933284 · Datex Division Instrumentarium Corp. · Jul 1994
HP M1465A STANDARD AIRWAY ADAPTER
K933980 · Hewlett-Packard Co. · Sep 1993
MASS SPECTROMETRY MONITORING LINE CONONECTORS
K925167 · Merit Medical Systems, Inc. · Jan 1993
VITALERT 3000 MONITORING SYSTEM
K913995 · Draeger Medical, Inc. · Nov 1992
DATASCOPE PASSPORT MONITOR WITH CO2
K921526 · Datascope Corp. · Oct 1992